https://www.technologynetworks.com/drug-discovery/news/pharmacopeia-advances-first-therapeutic-program-with-glaxosmithkline-205220
Pharmacopeia earns $500,000 milestone payment as a result of lead compound identification.
pharmacopeiaadvancesfirsttherapeuticprogram